Literature DB >> 457284

Suppression of tuberculin hypersensitivity during influenza infection in mice.

R M Massanari.   

Abstract

Tuberculin hypersensitivity was examined during acute influenza infection in mice. Employing the footpad test as a measure of delayed-type hypersensitivity, it was noted that tuberculin hypersensitivity was suppressed temporarily beginning on day 3 and continuing through days 10 to 16 following intranasal infection with influenza A/PR8. These changes occurred at a time when influenza virus was replicating in lung tissue. Suppression of footpad swelling was not detected when mice were administered live virus intravenously, were given Formalin-inactivated virus intranasally, or were immunized against influenza before intranasal infection. Transient reduction of total circulating lymphocytes also occurred during influenza infection but did not correlate with the duration of footpad suppression. Because this model system reproduces many of the alterations in immunological function reported to occur during influenza infection in humans, it should provide a useful tool for investigating mechanisms of influenza-induced immunosuppression.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 457284      PMCID: PMC414329          DOI: 10.1128/iai.24.2.501-507.1979

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  14 in total

1.  Effect of influenza virus on the immune responsiveness of animals.

Authors:  R E Kavetsky; Z D Savtsova; V I Struk; L V Yakimenko; Y A Umansky
Journal:  Acta Virol       Date:  1977-03       Impact factor: 1.162

2.  Tuberculin anergy and infectious mononucleosis.

Authors:  S Haider; M de L Coutinho; R T Emond; R N Sutton
Journal:  Lancet       Date:  1973-07-14       Impact factor: 79.321

3.  Cell-mediated immune responses in humans after induced infection with influenza A virus.

Authors:  R Dolin; D D Richman; B R Murphy; A S Fauci
Journal:  J Infect Dis       Date:  1977-05       Impact factor: 5.226

4.  Influenza A virus interaction with murine lymphocytes. I. The influence of influenza virus A/Japan 305 (H2N2) on the pattern of migration of recirculating lymphocytes.

Authors:  J J Woodruff; J F Woodruff
Journal:  J Immunol       Date:  1976-09       Impact factor: 5.422

5.  Decreased skin-test reactivity associated with influenza.

Authors:  W P Reed; J W Olds; A L Kisch
Journal:  J Infect Dis       Date:  1972-04       Impact factor: 5.226

6.  Effect of viral and bacterial pneumonias on cell-mediated immunity in humans.

Authors:  C A Kauffman; C C Linnemann; G M Schiff; J P Phair
Journal:  Infect Immun       Date:  1976-01       Impact factor: 3.441

Review 7.  Relations between immunity and malignancy.

Authors:  R A Good
Journal:  Proc Natl Acad Sci U S A       Date:  1972-04       Impact factor: 11.205

8.  Influenza in ferrets and guinea pigs: effect on cell-mediated immunity.

Authors:  C A Kauffman; G M Schiff; J P Phair
Journal:  Infect Immun       Date:  1978-02       Impact factor: 3.441

9.  Cell-mediated immunity in humans during viral infection. I. Effect of rubella on dermal hypersensitivity, phytohemagglutinin response, and T lymphocyte numbers.

Authors:  C A Kauffman; J P Phair; C C Linnemann; G M Schiff
Journal:  Infect Immun       Date:  1974-07       Impact factor: 3.441

10.  Studies on delayed hypersensitivity in mice. III. Evidence for suppressive regulatory T1-cell population in delayed hypersensitivity.

Authors:  S Morikawa; M Baba; T Harada; A Mitsuoka
Journal:  J Exp Med       Date:  1977-02-01       Impact factor: 14.307

View more
  2 in total

Review 1.  Pathogenicity of influenza virus.

Authors:  C Sweet; H Smith
Journal:  Microbiol Rev       Date:  1980-06

2.  Influenza and tuberculosis co-infection: A systematic review.

Authors:  Sibongile Walaza; Cheryl Cohen; Stefano Tempia; Jocelyn Moyes; Athermon Nguweneza; Shabir A Madhi; Meredith McMorrow; Adam L Cohen
Journal:  Influenza Other Respir Viruses       Date:  2019-09-30       Impact factor: 4.380

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.